Neonatal abstinence syndrome (NAS) is a result of the sudden discontinuation of fetal
exposure to substances that were used or abused by the mother during pregnancy …

Neonatal Abstinence Syndrome | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Context Neonatal abstinence syndrome (NAS) is a postnatal drug withdrawal syndrome
primarily caused by maternal opiate use. No national estimates are available for the …

In April 2016, the Eunice Kennedy Shriver National Institute of Child Health and Human
Development invited experts to a workshop to address numerous knowledge gaps and to …

A central goal of The Academy of Breastfeeding Medicine is the development of clinical
protocols for managing common medical problems that may impact breastfeeding success …

Abstract Purpose of the Review Opioid use disorder in the USA is rising at an alarming rate,
particularly among women of childbearing age. Pregnant women with opioid use disorder …

Neonatal abstinence syndrome (NAS) secondary to in-utero opioid exposure is an
increasing problem. Variability in assessment and treatment of NAS has been attributed to …

Aim To examine the rate and duration of breastfeeding in a cohort of women in opioid
maintenance treatment (OMT) in Norway, as well as the effect of breastfeeding on the …

METHODS: From 2012 to 2014, data were collected through serial cross-sectional audits of
participating centers. Hospitals assessed institutional policies and patient-level data for …

Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants
develop after intrauterine maternal drug exposure. All infants with documented in utero …